(NASDAQ: QTRX) Quanterix's forecast annual revenue growth rate of 2.91% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.81%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.36%.
Quanterix's revenue in 2025 is $137,421,000.On average, 2 Wall Street analysts forecast QTRX's revenue for 2025 to be $5,483,537,454, with the lowest QTRX revenue forecast at $5,425,954,785, and the highest QTRX revenue forecast at $5,541,120,123.
In 2026, QTRX is forecast to generate $6,418,625,710 in revenue, with the lowest revenue forecast at $6,256,928,923 and the highest revenue forecast at $6,580,322,498.